Lymphomas are a family of cancers that develop when immune-system cells called lymphocytes become cancerous (malignant). Lymphomas are divided into two general types: Hodgkin's disease and non-Hodgkin's lymphomas.
Memorial Sloan-Kettering specialists treat more than 450 lymphoma patients each year and see more than twice that number in consultation.
We also work continuously to improve the outcomes of lymphoma patients through clinical trials testing innovative new treatments as well as understanding the molecular mechanisms underlying these diseases.
In this section you can find information about our expertise in treating patients with lymphomas, our services, and our research.
A diagnosis of lymphoma can be a confusing and frightening event.
Our multidisciplinary team of experts can help you work through the
range of options available to you.
Select from the list below to learn more about our lymphoma specialists, their education, training, board certifications, current publications, and specific areas of clinical expertise.
Hodgkin lymphoma is a cancer that originates in the nodes of the lymphatic system, the collection of organs, tissues, and vessels that produce infection-fighting cells and carries them throughout the body.
Non-Hodgkin lymphoma is a group of cancers that originate in the lymphatic system, the collection of nodes, vessels, and organs that produces infection-fighting cells and carries them throughout the body.
Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for lymphomas. To learn more about a study, choose from the list below.
